Effects of cyclophosphamide on the immune system and disease resistance of Asian catfish Clarias batrachus.
Cyclophosphamide (CYP), a multifunctional alkylating agent is known as a potent immunosuppressor in endotherms. Here, an experiment was conducted in an ectothermic Asian catfish species, Clarias batrachus to investigate its effect on non-specific and specific immunity as well as disease resistance against a common bacterial pathogen challenge. CYP was intraperitoneally injected for 3 consecutive days at a rate of 200 mgkg(-1) body weight. After 72 h post-injection, control and CYP-treated fish were screened for superoxide production through nitroblue tetrazolium (NBT) assay, myeloperoxidase (MPO) activity, packed cell volume (PCV) and total protein, lysozyme, alternative complement activity (ACH50) and natural haemagglutinin titre as a measure of non-specific immunity level as well as disease resistance against Aeromonas hydrophila challenge to vaccinated and unvaccinated fish. To study the effect on specific immunity, CYP was injected thrice at an interval of 7 days after bacterin injection and serum antibody titre was measured by bacterial agglutination titre assay. The results showed a significant (P<0.05) decrease in NBT and MPO activities, and percent survival against A. hydrophila challenge (both in unvaccinated and vaccinated fish) in CYP-treated fish, when compared to control fish. The above results support the immunosuppressive action of CYP in freshwater catfish, C. batrachus. The neutrophil activities, as measured through superoxide production and myeloperoxidase levels, might be important contributors during A. hydrophila infection and that treatment with CYP reduces phagocytic killing power and inhibits resistance against aeromoniasis.
Kumari
Jaya
J
Central Institute of Freshwater Aquaculture, Kausalyaganga, Bhubaneswar 751 002, India.
Sahoo
P K
PK
D016980:Aeromonas hydrophila / Q000276:immunology*; D000818:Animals; D001786:Blood Glucose; D002397:Catfishes; D003170:Complement Pathway, Alternative / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology*; D005393:Fish Diseases / Q000276:immunology* / Q000382:microbiology*; D016905:Gram-Negative Bacterial Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D006400:Hematocrit / Q000662:veterinary; D006854:Hydrocortisone / Q000097:blood; D007113:Immunity, Innate / Q000187:drug effects* / Q000276:immunology; D007165:Immunosuppression Therapy / Q000662:veterinary*; D007274:Injections, Intraperitoneal; D009113:Muramidase; D009580:Nitroblue Tetrazolium; D009195:Peroxidase / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D016019:Survival Analysis
D001786:Blood Glucose; D011506:Proteins; D013481:Superoxides; D009580:Nitroblue Tetrazolium; D003520:Cyclophosphamide; D009195:Peroxidase; D009113:Muramidase; D006854:Hydrocortisone